Myxoid/Round Cell Liposarcoma
Showing 1 - 25 of >10,000
Tumors Trial in United States (letetresgene autoleucel (GSK3377794), Cyclophosphamide, Fludarabine)
Completed
- Neoplasms
- letetresgene autoleucel (GSK3377794)
- +2 more
-
Tampa, Florida
- +5 more
Oct 31, 2022
Tumors Trial in Worldwide (Letetresgene autoleucel)
Active, not recruiting
- Neoplasms
- Letetresgene autoleucel
-
Pittsburgh, Pennsylvania
- +5 more
Aug 7, 2023
Hepatocellular Carcinoma, Squamous Cell Carcinoma of the Lung, Merkel Cell Carcinoma Trial in Houston, Milwaukee (CAR-GPC3 T
Recruiting
- Hepatocellular Carcinoma
- +3 more
- CAR-GPC3 T Cells
-
Dallas, Texas
- +2 more
Dec 20, 2022
Synovial Sarcoma Trial in Houston (Fludarabine phosphate, NY-ESO-1 TCR/IL-15 NK, Cyclophosphamide)
Not yet recruiting
- Synovial Sarcoma
- Fludarabine phosphate
- +2 more
-
Houston, TexasMD Anderson Cancer Center
Oct 9, 2023
Synovial Sarcoma, Myxoid Liposarcoma Trial in Worldwide (afamitresgene autoleucel (previously ADP-A2M4))
Recruiting
- Synovial Sarcoma
- Myxoid Liposarcoma
- afamitresgene autoleucel (previously ADP-A2M4)
-
Duarte, California
- +26 more
Dec 7, 2022
Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma Trial in Seattle
Recruiting
- Metastatic Leiomyosarcoma
- +17 more
- Itacitinib
- Laboratory Biomarker Analysis
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 13, 2022
Urinary Bladder Cancer, Melanoma, Head Neck Cancer Trial in Canada, United States (Autologous genetically modified MAGE-A4?¹º³²T
Active, not recruiting
- Urinary Bladder Cancer
- +9 more
- Autologous genetically modified MAGE-A4ᶜ¹º³²T cells
- Autologous genetically modified MAGE-A4c1032T cells combined with low dose radiation
-
Miami, Florida
- +10 more
Aug 9, 2022
Ewing Sarcoma, Myxoid Liposarcoma, Desmoplastic Small Round Cell Tumor Trial in Santa Monica (Seclidemstat)
Enrolling by invitation
- Ewing Sarcoma
- +8 more
-
Santa Monica, CaliforniaSarcoma Oncology Center
Feb 23, 2022
Ewing Sarcoma, Myxoid Liposarcoma, Sarcoma,Soft Tissue Trial in United States (Seclidemstat, Cyclophosphamide, Topotecan)
Recruiting
- Ewing Sarcoma
- +10 more
- Seclidemstat
- +2 more
-
Los Angeles, California
- +16 more
Jan 18, 2022
Liposarcoma, Myxoid, Liposarcoma, Dedifferentiated, Liposarcoma, Round Cell Trial (Trabectedin, Pioglitazone Oral Product)
Not yet recruiting
- Liposarcoma, Myxoid
- +2 more
- Trabectedin
- Pioglitazone Oral Product
- (no location specified)
Mar 10, 2021
Multiple Myeloma, Melanoma, Synovial Sarcoma Trial in Philadelphia (biological, drug, device)
Terminated
- Multiple Myeloma
- +3 more
- NY-ESO-1 redirected autologous T cells with CRISPR edited endogenous TCR and PD-1
- +3 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Oct 9, 2020
Metastatic Myxoid Liposarcoma, Metastatic Round Cell Liposarcoma, Metastatic Synovial Sarcoma Trial in United States (Interferon
Active, not recruiting
- Metastatic Myxoid Liposarcoma
- +15 more
- Interferon Gamma-1b
- +2 more
-
Palo Alto, California
- +6 more
Aug 2, 2022
Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor Trial in Portland, Seattle
Completed
- Adult Alveolar Soft Part Sarcoma
- +18 more
- Gemcitabine
- +5 more
-
Portland, Oregon
- +1 more
Sep 23, 2021
Sarcoma, Myxoid/Round Cell Liposarcoma, Synovial Sarcoma Trial in United States (CMB305, atezolizumab)
Terminated
- Sarcoma
- +6 more
- CMB305
- atezolizumab
-
Palo Alto, California
- +17 more
Jun 26, 2020
HLA-A*0201 Positive Cells Present, NY-ESO-1 Positive Tumor Cells Present, Recurrent Myxoid Liposarcoma Trial in Houston
Active, not recruiting
- HLA-A*0201 Positive Cells Present
- +3 more
- Aldesleukin
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Feb 25, 2022
Myxoid Liposarcoma, Round Cell Liposarcoma, Synovial Sarcoma Trial in Seattle (Laboratory Biomarker Analysis, Recombinant
Terminated
- Myxoid Liposarcoma
- +2 more
- Laboratory Biomarker Analysis
- Recombinant Interferon Gamma
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jun 19, 2019
Epithelioid Sarcoma (Ex-US Only), Spindle Cell Sarcoma, Sinonasal Carcinoma Trial (Tazemetostat)
Temporarily not available
- Epithelioid Sarcoma (Ex-US Only)
- +19 more
- (no location specified)
Oct 17, 2022
Malignant Abdominal Tumor, Malignant Pelvic Tumor, Recurrent Colon Carcinoma Trial in Rochester (Cisplatin, Cytoreductive
Recruiting
- Malignant Abdominal Neoplasm
- +26 more
- Cisplatin
- +4 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 5, 2023
Tumors Trial in Worldwide (Letetresgene autoleucel (lete-cel, GSK3377794), Fludarabine, Cyclophosphamide)
Active, not recruiting
- Neoplasms
- Letetresgene autoleucel (lete-cel, GSK3377794)
- +2 more
-
Duarte, California
- +36 more
Oct 28, 2022
Myxoid Liposarcoma, Round Cell Liposarcoma, Stage III Soft Tissue Sarcoma AJCC v7 Trial in Seattle (procedure, other, drug)
Withdrawn
- Myxoid Liposarcoma
- +5 more
- Biopsy
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 6, 2019
Sarcoma, Alveolar Soft Part Sarcoma, Clear Cell Sarcoma Trial in Warsaw (Hypofractionated radiotherapy, Hyperthermia)
Active, not recruiting
- Sarcoma
- +10 more
- Hypofractionated radiotherapy
- Hyperthermia
-
Warsaw, Mazovian, PolandMaria Sklodowska-Curie Institute - Oncology Center
Jan 27, 2021